The application of CGMS offers novel possibilities to define the impact of different exercise parameters like exercise duration, frequency and intensity on glycemic control in type 2 diabetes patients. In addition we are interested in the impact on…
ID
Source
Brief title
Condition
- Glucose metabolism disorders (incl diabetes mellitus)
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Probabely all parameters decribed above will influence blood glucose level.
With use of CGMS it will be possible to investigate blood glucose 24 hours
before and after exercise training.
Addendum:
With the use of CGM glucose excursions during and after exercise will be tested
Secondary outcome
not applicable
Background summary
For some years, it is obvious that exercise training and medication have
positive influence on lowering insulin sensitivity diabetes type 2 patients
have to cope with. Recently it became possible to measure the effect of the
parameters mentioned above. By Introducing ambulatory continue glucose
measuring, it became possible to evaluate glucose concentrations very precisely
for a 48 hours period.
Study objective
The application of CGMS offers novel possibilities to define the impact of
different exercise parameters like exercise duration, frequency and intensity
on glycemic control in type 2 diabetes patients. In addition we are interested
in the impact on blood glucose concentrations when glucose or Niaspan® is
ingested just before exercise.
Addendum:
Optimizing and validating the calibration protocols for continuous measurement
of glucose concentrations during exercise with CGM
Study design
In order to investigate these questions we therefore propose the following
trials (as described in sections A through E) to assess the efficacy of the
main exercise training modalities to improve glycemic control. The described
studies will provide a clear description of the characteristics of an optimal
exercise intervention program for type 2 diabetes patients.
Intensity High versus low intensity
Sort of exercise duration versus weight training
Frequention Daily versus once every day exercise
Niaspan Exercise with versus exercise without use of Niaspan
Glucose Exercise with versus exercise without use of glucose beverage
Every parameter will be studied with use of 3 trials: During two trial subjects
will perform exercise and in a third trial the subjects will refrain from
exercise (i.e. control trial).
Addendum:
Cross-over study in which the effects of exercise on sensor validity en the
applied calobration protocols will be tested. Every subject will perform 2
tests: exercise and rest
Intervention
Intensity High versus low intensity training
Sort of exercise duration versus weight training
Frequention Daily versus once every day exercise
Niaspan Exercise with versus exercise without use of Niaspan
Glucose Exercise with versus exercise without use of glucose beverage
All exercise training will be done on a cycle ergo meter, except from
weighttraining. This training uses equipment decribed in section B of the study.
Addendum:
Exercise for 60 min at 50% Wmax
Study burden and risks
Risks as the result of participation in this experiment are minimal. Estimating
maximum workload capacity in a Wmax test is always done with a physician and MD
present. All Wmax will be done with use of ECG recording for all patients.
Previous studies have shown that wearing the CGMS does not hamper the subject
in his normal functioning. Withholding oral blood glucose lowering medication
for a period of two days does not result in a serious disturbance of blood
glucose homeostasis and blood glucose concentrations will be normalized within
1-2 days after the screening. After the screening, subjects can resume their
normal medication routine. We chose this method because we want to assess the
patients* normal reaction to glucose under normal uncontrolled conditions.
Screening 4 hours
Wearing CGMS 46 hours
Visiting University 5 hours
Exercise intervention 2 hours
Every trial consist of 3 tests, so subjects spent 3 time 50 hour for this
study. In this period of time, they will be visiting the university 15 hours.
Addendum:
Screening 3 hours
testdays 7 hours (on one day 1h of exercise and in the other
day 1h of rest)
postbus 616
6200 MD Maastricht
Nederland
postbus 616
6200 MD Maastricht
Nederland
Listed location countries
Age
Inclusion criteria
BMI between 25 and 35, male, oral medication, age between 40 and 60 year
Exclusion criteria
impaired renal or liver function, obesity (BMI>35), cardiac disease, hypertension, diabetes complications, exogenous insulin therapy
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL13054.068.06 |